The United Laboratories International Holdings (ULIHF) Stock Statistics & Valuation Metrics

The United Laboratories International Holdings has a market cap or net worth of $1.72B. The enterprise value is $10.04B.

Market Cap

$1.72B

Enterprise Value

$10.04B

The United Laboratories International Holdings has 1,970,276,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,970,276,500

Owned by Insiders

―

Owned by Institutions

8.25%

The United Laboratories International Holdings’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.15%.

Return on Equity (ROE)

0.12

Return on Assets (ROA)

0.07

Return on Invested Capital (ROIC)

8.15%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

733.92K

Profits Per Employee

115.88K

Employee Count

18,000

Asset Turnover

0.43

Inventory Turnover

3.25

The current PE Ratio of The United Laboratories International Holdings is 20.80. The United Laboratories International Holdings’s PEG ratio is -0.25.

PE Ratio

20.80

PS Ratio

0.96

PB Ratio

0.66

Price to FCF

48.15

Price to Operating Cash Flow

6.25

PEG Ratio

-0.25

In the last 12 months, The United Laboratories International Holdings had revenue of 13.21B and earned 2.09B in profits. Earnings per share was 1.11.

Revenue

13.21B

Gross Profit

5.51B

Operating Income

2.27B

Pretax Income

2.53B

Net Income

2.09B

EBITDA

2.87B

Earnings Per Share (EPS)

1.11

In the last 12 months, operating cash flow was 1.83B and capital expenditures -1.59B, giving a free cash flow of 236.66M billion.

Operating Cash Flow

1.83B

Free Cash Flow

236.66M

Free Cash Flow per Share

0.12

The United Laboratories International Holdings pays an annual dividend of $0.04, resulting in a dividend yield of 4.37%

Dividend Per Share

$0.04

Dividend Yield

4.37%

Payout Ratio

35.62%

Free Cash Flow Yield

2.08%

Earnings Yield

4.73%

Beta

-0.28

52-Week Price Change

-53.39%

50-Day Moving Average

1.01

200-Day Moving Average

1.28

Relative Strength Index (RSI)

31.81

Average Volume (3m)

1,007

The United Laboratories International Holdings upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 31, 2026

Next Earnings Date

Mar 30, 2027

Ex-Dividend Date

Jul 09, 2026

The United Laboratories International Holdings as a current ratio of 1.83, with Debt / Equity ratio of 28.70%

Current Ratio

1.83

Quick Ratio

1.60

Debt to Market Cap

0.25

Net Debt to EBITDA

-2.18

Interest Coverage Ratio

32.58

In the past 12 months, The United Laboratories International Holdings has paid 446.87M in taxes.

Income Tax

446.87M

Effective Tax Rate

0.18

The United Laboratories International Holdings EV to EBITDA ratio is 4.38, with an EV/FCF ratio of 23.73.

EV to Sales

0.47

EV to EBITDA

4.38

EV to Free Cash Flow

23.73

EV to Operating Cash Flow

3.08

The United Laboratories International Holdings has $11.73B in cash and marketable securities with $5.95B in debt, giving a net cash position of $5.78B billion.

Cash & Marketable Securities

$11.73B

Total Debt

$5.95B

Net Cash

$5.78B

Net Cash Per Share

$2.93

Tangible Book Value Per Share

$8.61

Gross margin is 31.28%, with operating margin of 4.64%, and net profit margin of 4.55%.

Gross Margin

31.28%

Operating Margin

4.64%

Pretax Margin

4.84%

Net Profit Margin

4.55%

EBITDA Margin

10.80%

EBIT Margin

4.48%

The average price target for The United Laboratories International Holdings is $1.38, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

$1.38

Price Target Upside

58.26% Upside

Analyst Consensus

Strong Buy

Analyst Count

4

Revenue Growth Forecast

-13.11%

EPS Growth Forecast

-83.15%

Smart Score

3

AI Score

―